Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention

Percutaneous coronary intervention (PCI) with stent placement is a standard treatment for coronary artery disease (CAD). In-stent restenosis after PCI remains a challenging clinical problem. In China, Chinese herbal medicines (CHMs) are widely used for preventing restenosis. This paper systematicall...

Full description

Bibliographic Details
Main Authors:	Guo-Hua Zheng, Jian-Ping Liu, Nissi S. Wang, Hai-Ying Chen, Jian-Feng Chu
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2012/253409

Similar Items

Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
by: Dedi Wihanda, et al.
Published: (2015-07-01)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
by: Hyung Joon Joo, et al.
Published: (2018-06-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Alternative approaches to the prevention of coronary in-stent restenosis
by: Robertson, Keith Euan
Published: (2014)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
by: Lizhi Lv, et al.
Published: (2019-07-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
by: Yong Zhu, et al.
Published: (2021-07-01)

Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
by: Jian-Feng Zheng, et al.
Published: (2020-11-01)

The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do
by: Pengfei Wang, et al.
Published: (2020-12-01)

Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention
by: Wenbo He, et al.
Published: (2021-09-01)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005-10-01)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005-03-01)

Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis.
by: Shi-Jie Zhao, et al.
Published: (2016-01-01)

Homocysteine and malondialdehyde as predictors of restenosis following percutaneous coronary intervention
by: McNair, Erick
Published: (2006)

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
by: Meier Pascal, et al.
Published: (2012-06-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)

In-stent restenosis after primary percutaneous coronary intervention: focal versus diffuse pattern. Influence of clinical profile and type of stent
by: Iván Javier Núñez-Gil, et al.
Published: (2020-02-01)

A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
by: Muhsin Kalyoncuoglu, et al.
Published: (2021-01-01)

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
by: Cheng-Ping Hu, et al.
Published: (2018-01-01)

Bioresorbable scaffolds for coronary artery in-stent restenosis
by: Arindam Pande, et al.
Published: (2015-12-01)

A unique case of coronary in stent restenosis
by: R. Girish, et al.
Published: (2015-12-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis
by: Hai-Wei Miao, et al.
Published: (2015-12-01)

Changes of miR-130a and ET-1 and Their Predictive Value for In-Stent Restenosis after Percutaneous Coronary Intervention
by: Hongliang LIU, et al.
Published: (2020-03-01)

Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
by: Chen Die Yang, et al.
Published: (2020-09-01)

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study
by: Zheng Qin, et al.
Published: (2019-01-01)

Markers of inflammation and antioxidant enzyme activities in restenosis following percutaneous coronary intervention
by: Pantović Snežana, et al.
Published: (2015-01-01)

Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia
by: M.O. Lima-Filho, et al.
Published: (2010-06-01)

Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
by: Jichen Liu, et al.
Published: (2015-01-01)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

The kinetics and efficacy of activated protein C-eluting coronary stents : preventing thrombosis in percutaneous coronary intervention
by: Sik-Yin Foo, Roger
Published: (2000)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

Clinical and angiographic assessment of coronary bare-metal stent restenosis
by: Max G. Sánchez Manzanares, et al.
Published: (2017-02-01)

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
by: Zsolt Bagyura, et al.
Published: (2017-01-01)

Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention
by: Fernando S. Montenegro, et al.
Published: (2018-05-01)

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
by: Lankisch Mark, et al.
Published: (2009-10-01)

The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus
by: Zijlstra Felix, et al.
Published: (2009-07-01)

Soluble receptors for advanced glycation end products as predictors of restenosis following percutaneous coronary intervention
by: McNair, Erick Donnell
Published: (2009)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

The problem ofpreventing vascular restenosis after implantation of a coronary stent
by: А В Sumarokov, et al.
Published: (2004-08-01)

Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
by: Amira Shoukry, et al.
Published: (2012-03-01)